Effect of angiotensin-converting enzyme inhibition on bronchial responsiveness

Journal of Clinical Pharmacology

Volumn 36, Issue 4, 1996, Pages 361-364

  Dicpinigaitis, Peter V ^a,b   Dobkin, Jay B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Jack D Weiler Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; BRONCHOCONSTRICTING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; METHACHOLINE; PLACEBO; SUBSTANCE P;

ADULT; ARTICLE; BRONCHOSPASM; BRONCHUS REACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME INHIBITION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL;

EID: 0029930544     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb04213.x     Document Type: Article

References (24)

1. Materson BJ, Preston RA: Angiotensin-converting enzyme inhibitors in hypertension. Arch Intern Med 1994;154:513-523.
2. The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327: 685-691.
3. Ambrosioni E, Borghi C, Magnani B: The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995;332: 80-85.
4. Israili ZH, Hall WD: Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med 1992;117:234-242.
5. Ravid D, Lishner M, Lang R, Ravid M: Angiotensin-converting enzyme inhibitors and cough: a prospective evaluation in hypertension and in congestive heart failure. J Clin Pharmacol 1994; 34: 1116-1120
6. Subissi A, Guelfi M, Criscuoli M: Angiotensin converting enzyme inhibitors potentiate the bronchoconstriction induced by substance P in the guinea-pig. Br J Pharmacol 1990;100:502-506.
7. Lunde H, Hedner T, Samuelsson O, Lotvall J, Andren L, Lindholm L. et al: Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors. Br Med J 1994;308:18-21.
8. Wood R: Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril: a controlled retrospective cohort study. Br J Clin Pharmacol 1995;39:267-270.
9. Popa V: Captopril-related (and -induced?) asthma. Am Rev Respir Dis 1987;136:999-1000.
10. Hinojosa M, Quirce S, Puyana J, Codina J, Rull SG: Bronchial hyperreactivity and cough induced by angiotensin-converting enzyme-inhibitor therapy. J Allergy Clin Immunol 1990;85:818-819.
11. Goh TC, Ong YY: Bronchial hyperreactivity induced by angiotensin converting enzyme inhibitor. Singapore Med J 1991;32: 183-184.
12. Bucknall CE, Neilly JB, Carter R, Stevenson RD, Semple PF: Bronchial hyperreactivity in patients who cough after receiving angiotensin converting enzyme inhibitors. Br Med J 1988;296:86-88.
13. Lindgren BR, Rosenqvist U, Ekstrom T, Gronneberg R, Karlberg BE, Andersson RGG: Increased bronchial reactivity and potentiated skin responses in hypertensive subjects suffering from coughs during ACE-inhibitor therapy. Chest 1989;95:1225-1230.
14. Sala H, Abad J, Juanmiquel L, Plans C, Ruiz J, Roig J, et al: Captopril and bronchial reactivity. Postgrad Med J 1986;62(suppl 1):76-77.
15. Dixon CMS, Fuller RW, Barnes PJ: The effect of an angiotensin converting enzyme inhibitor, ramipril, on bronchial responses to inhaled histamine and bradykinin in asthmatic subjects. Br J Clin Pharmacol 1987;23:91-93.
16. Kaufman J, Schmitt S, Barnard J, Busse W: Angiotensin-converting enzyme inhibitors in patients with bronchial responsiveness and asthma. Chest 1992;101:922-925.
17. Town GI, Hallwright GP, Maling TJB, O'Donnell TV: Angiotensin converting enzyme inhibitors and cough. N Z Med J 1987;100:161-163.
18. Boulet L-P, Milot J, Lampron N, Lacourciere Y: Pulmonary function and airway responsiveness during long-term therapy with captopril. JAMA 1989;261:413-416.
19. Kaufman J, Casanova JE, Riendl P, Schlueter DP: Bronchial hyperreactivity and cough due to angiotensin-converting enzyme inhibitors. Chest 1989;95:544-548.
20. Overlack A, Muller B, Schmidt L, Scheid M-L, Muller M, Stumpe KO: Airway responsiveness and cough induced by angiotensin converting enzyme inhibition. J Hum Hypertens 1992;6: 387-392.
21. Juniper EF, Frith PA, Dunnett C, Cockcroft DW, Hargreave FE: Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax 1978;33:705-710.
22. Malo J-L, Pineau L, Cartier A, Martin RR: Reference values of the provocative concentrations of methacholine that cause 6% and 20% changes in forced expiratory volume in one second in a normal population. Am Rev Respir Dis 1983;128:8-11.
23. Chai H, Farr RS, Froehlich LA, Mathison DA, McLean JA, Rosenthal RR, et al: Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323-327.
24. Hargreave FE, Ryan G, Thomson NC, O'Byrne PM, Latimer K, Juniper EF, et al: Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol 1981;68:347-355.